Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity

Table 3 ANCOVA results for Hamilton Anxiety Rating Scale (HAM-A)

Source	SS	df	MS	F	p	Partial η²
Corrected model	34.307	3	11.436	0.314	0.815	0.017
Intercept	126.327	1	126.327	3.469	0.068	0.060
Job	5.479	1	5.479	0.150	0.700	0.003
Baseline HAM-A (covariate)	21.133	1	21.133	0.580	0.449	0.011
Group (ketamine vs. buprenorphine)	11.510	1	11.510	0.316	0.576	0.006
Error	1966.314	54	36.413
Total	4260.000	58
Corrected total	2000.621	57

ISSN: 1745-6215